Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

S-cone Stimulation Opposes Aversion to Melanopsin and L-cone Stimulation in a Preclinical Model of Photophobia
Headache
S20 - Hot Topics in Headache (3:42 PM-3:54 PM)
002

Intrinsically photosensitive retinal ganglion cells (ipRGCs), which transmit melanopsin and cone signals, have been implicated in mediating visual discomfort in humans and amplified in those with migraine. Aversion to light after triggers (e.g. calcitonin gene-related peptide, CGRP) has been used as a preclinical model of migraine, but the photoreceptor basis of this behavior has yet to be examined.

To measure avoidance to stimuli targeting melanopsin, L-cones, and/or S-cones in a mouse model of migraine.

Transgenic red cone knock-in (RCKI, B6.129-Opn1mwtm1(OPN1LW)Nat/J) mice were studied. Light avoidance was tested in a two-zone chamber that was illuminated by narrow-band LEDs that targeted photopic opsins: 365 nm (UV; rodent S-cone), 460 nm (blue; melanopsin), and 630 nm (red; human L-cone). The zones were set to differing relative contrast levels (0.50 to 1.00) for the targeted photoreceptor. Mice were examined without intervention and following peripheral CGRP (0.1 mg/kg, ip) or vehicle administration every other day for 9 days. A key measure was the asymptotic ratio of time in the high versus low contrast zone.

RCKI mice spent less time in the zone with the higher melanopsin (0.481 ± 0.082, n = 18) or L-cone (0.697 ± 0.113, n = 15) contrast but more time in the zone with the higher S-cone (1.348 ± 0.056, n = 16) contrast. These effects diminished with less relative contrast between the two zones. Furthermore, adding S-cone contrast to melanopsin (0.898 ± 0.122, n = 14) or L-cone (1.158 ± 0.071, n = 45) contrast ameliorated avoidance of these stimuli. Avoidance of ipRGC stimulation was heightened by day 9 of CGRP priming.

The aversion to melanopsin and L-cone stimulation is consistent with ipRGCs responses observed in humans. S-cone stimulation may attenuate ipRGC signals, whereas CGRP may amplify ipRGC signals in migraine-associated photophobia.

Authors/Disclosures
Eric Kaiser, MD, PhD (Hospital of the University of Pennsylvania)
PRESENTER
The institution of Dr. Kaiser has received research support from Amgen. Dr. Kaiser has received intellectual property interests from a discovery or technology relating to health care.
Audrey Cavanah (University of Pennsylvania) No disclosure on file
Geoffrey K. Aguirre, MD, PhD (University of Pennsylvania, Department of Neurology) Dr. Aguirre has received stock or an ownership interest from Nia therapeutics. The institution of Dr. Aguirre has received research support from Lion's Foundation. The institution of Dr. Aguirre has received research support from National Institutes of Health. The institution of Dr. Aguirre has received research support from Johnson and Johnson. The institution of Dr. Aguirre has received research support from Department of Defense.
Frances E. Jensen, MD, FAAN (Hospital of the University of Pennsylvania,Neurology Department) Dr. Jensen has received research support from Passages Bio.